LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹1.82 Cr | ₹2.44 Cr | ₹3.47 Cr | ₹3.66 Cr | ₹3.86 Cr |
What is the latest Long Term Provisions ratio of LYKA LABS ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹1.82 Cr |
Mar2023 | ₹2.44 Cr |
Mar2022 | ₹3.47 Cr |
Mar2021 | ₹3.66 Cr |
Mar2020 | ₹3.86 Cr |
How is Long Term Provisions of LYKA LABS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹1.82 Cr | -25.27 | |
Mar2023 | ₹2.44 Cr | -29.72 | |
Mar2022 | ₹3.47 Cr | -5.27 | |
Mar2021 | ₹3.66 Cr | -5.18 | |
Mar2020 | ₹3.86 Cr | - |
Compare Long Term Provisions of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹556.0 Cr | -1.3% | -3.7% | 22.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -3.7% | -2.5% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | 2.3% | 2.1% | 46.9% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.2% | 0% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -2.4% | 7.3% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | 2% | 2.3% | 37.9% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -1.3% |
-3.7% |
22.8% |
SENSEX | -2.2% |
-5.9% |
7.2% |
You may also like the below Video Courses